Britain aims to make gene testing accessible for cancer patients

Britain has launched a research program designed to eventually allow all cancer patients to have access to genetic analysis. The project, involving the Institute of Cancer Research (ICR) in London, the U.S. gene sequencing firm Illumina, geneticists and cancer doctors, aims to find a way to allow more cancer genes to be tested in more people. Read more here.